HCW Biologics Inc (HCWB) — Long-term Investment Intensity
HCW Biologics Inc (HCWB) has a Long-term Investment Intensity of 5.4% as of December 2025. Long-term investments of $1.33 Million represent 5.4% of total assets of $24.52 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See HCWB book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
HCW Biologics Inc Long-term Investment Intensity (2020–2025)
This chart shows how HCW Biologics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 5.4%, reflecting long-term investments of $1.33 Million against total assets of $24.52 Million USD. Also explore HCW Biologics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for HCW Biologics Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for HCW Biologics Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see HCWB market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.4% | $1.33 Million | $24.52 Million | ▲ +0.1 pp |
| 2024 | 5.3% | $1.60 Million | $30.24 Million | ▼ -0.3 pp |
| 2023 | 5.6% | $1.60 Million | $28.51 Million | ▲ +2.2 pp |
| 2022 | 3.4% | $1.60 Million | $46.81 Million | ▼ -18.1 pp |
| 2021 | 21.5% | $11.52 Million | $53.51 Million | ▲ +11.1 pp |
| 2020 | 10.4% | $1.60 Million | $15.40 Million | — |